Medical Oncology Grand Rounds


Grand Rounds begin each year in September after completion of the introductory lecture series. Fellows and faculty members give 30- to 60-minute, case-based discussions and literature reviews on subjects of their choosing.

Viewing presentations

Presentations can be viewed on the Oncology Learning Portal. Registration is required.


Friday, Noon-1:00 PM
11th Floor Mid-Campus Center (unless otherwise noted)

2017-2018 Academic Year

Date Speaker Title
Aug 25, 2017 Nusayba Bagegni Overcoming Drug Resistance in HER2+ Breast Cancer
Sep 1, 2017 Ravi Vij MM: AK47 or M24
Sep 15, 2017 Natasha Edwin Physician Immigration and the US
Sep 22, 2017 Jeffrey S. Miller, MD
University of Minnesota
Novel Ways to Activate NK Cells to Treat Cancer
Sep 29, 2017 Emily Jungheim, MD, MSCI
Obstetrics and Gynecology
Fertility Preservation in 2017 at Washington University
Oct 6, 2017 Brad Kahl Mantle Cell Lymphoma: The State of the State
Oct 13, 2017 Craig H. Moskowitz, MD
Memorial Sloan Kettering Cancer Center
Hodgkin Lymphoma in the Near Future: Impact of Modern Nuclear Medicine, Radiotherapy, Brentuximab Vedotin and the Checkpoint Inhibitors
Oct 20, 2017 Miriam Jacobs Immunotherapy in Metastatic Squamous Cell Head and Neck Cancer
Ramon Jin Cancer Stem Cells in Solid Tumors
Oct 27, 2017 Bita Fakhri Current and Emerging Treatment Strategies for Relapsed and Refractory Multiple Myeloma
Nov 3, 2017 Ron Bose Her2 Activating Mutations and the Challenge of Variants of Unknown Significance (VUS) in Breast Cancer Patients
Nov 10, 2017 Daniel J. Lenihan, MD
Cardiovascular Division
Cardio Oncology: How Can We Improve Practice?
Nov 17, 2017 Eric Huselton Improving Outcomes After Allogeneic Tranplant: Risk Factors and Treatment of Relapsed AML
Dec 1, 2017 Ramzi Abboud JAK/STAT Pathways and Immunomodulation After Hematopoietic Cell Transplantation and Other Immune Therapies
Brett Herzog Clonal Dynamics of Non-Small Cell Lung Cancer
Dec 15, 2017 Doug Adkins Current Clinical Investigations in Head and Neck Cancer at Washington University
Dec 22, 2017 Vivek Arora Emerging Concepts in Bladder Cancer Management
Jan 5, 2018 Brian Van Tine Sarcoma Metabolism
Jan 12, 2018 Neha Mehta-Shah T-Cell Lymphomas: Where We Are and Where We Hope to Be
Jan 19, 2018 Brigitte C. Widemann, MD
Pediatric Oncology Branch, NCI
Development of Effective Therapies for NF1 Related Peripheral Nerve Sheath Tumors
Jan 26, 2018 Daniel Guy Age-Related Clonal Hematopoiesis
Amber Xu Past, Present and Future of PARP Inhibition
Feb 2, 2018 Lawrence Einhorn, MD
Indiana University
Testicular Cancer: Past History, Present Results and Future Perspectives
Feb 9, 2018 Bruna Pellini Ferreira Cell Tumor DNA in the Diagnosis and Follow-Up of NSCLC
Nkiruka Ezenwajiaku Mixed Phenotype Acute Leukemia
Feb 16, 2018 John P. Leonard, MD
Weill Cornell Medical College
New Developments in Lymphoma: Progress and Problems in Precision Therapy
Feb 23, 2018 David T. Curiel, MD, PhD
Radiation Oncology
Molecular Engineering of Adenovirus to Actualize Cancer Vaccines
Mar 2, 2018 Thomas M. Maddox, MD, MSc
Cardiovascular Division
The Health Systems Innovation Lab: Opportunities to Think Differently About Cancer Care
Mar 9, 2018 Monte Meier Winslow, PhD
Stanford University
Molecular Determinants of Lung Cancer Growth and Metastasis
Mar 16, 2018 Daniel Guy Prevention of CMV Infection in Patients Undergoing HSCT
Aabha Oza Progressive Multifocal Leukoencephaolpathy
Mar 30, 2018 Russell W. Jenkins, MD, PhD
Dana-Farber/Harvard Cancer Center
Ex-Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids: Developing a Functional Precision Medicine Platform for Immuno-Oncology
Apr 6, 2018 Ramon Jin Metaplasia: The Calm Before the Storm?
Patrick Grierson Targeting the MAPK Pathway in Solid Tumors
Apr 13, 2018 Lee Ratner Pathogenesis and Treatment of Human T-Cell Leukemia Virus Associated Malignancy
Apr 20, 2018 John DiPersio Therapeutic Targeting of Hematologic Malignancies
Apr 27, 2018 Jeff Ward Remodeling of Intratumoral Myeloid and Lymphoid Compartments Following Immune Checkpoint Blockade Therapy
May 18, 2018 Jeffrey A. Moscow, MD
Cancer Therapy Evaluation Program, NCI
Precision Cancer Medicine and the NCI's Experimental Therapeutics Clinical Trials Network (ETCTN)
May 25, 2018 Russell Pachynski Chemerin in Cancer
Jun 8, 2018 Matthew A. Ciorba, MD
Gastroenterology Division
Save IDO Inhibitors! A Role for Tryptophan Metabolism in Colon Cancer
Jun 15, 2018 Francesca Ferraro From MGUS to MGCS: When the "Uncertain" Turns to "Ugly"
Amber Afzal BCL2 Inhibition in Myeloid Malignancies
Jun 22, 2018 Gad Getz, PhD
Harvard Medical School
Studying Response and Resistance to Therapy in Cancer
Jun 29, 2018 Pasi A. Jänne, MD, PhD
Harvard Medical School
New Therapeutic Stratgies for EGFR Mutant Lung Cancer